Intravenous combined with topical application of tranexamic acid in primary total hip arthroplasty: a meta-analysis of efficacy and safety

doi:10.3969/j.issn.2095-4344.2017.03.025

Abstract

Abstract:

BACKGROUND: In the total hip arthroplasty, intravenous and topical tranexamic acid can significantly reduce the perioperative blood loss and blood transfusion rate, but at present, the clinical application of tranexamic acid is still controversial.

OBJECTIVE: Cochrane system evaluation method is applied on the efficacy and safety of intravenous combined with topical application versus single-dose intravenous application of tranexamic acid in the total hip arthroplasty.

METHODS: We searched the Cochrane Library, PubMed, Ovid, EMBASE, CBM, Wanfang, VIP and CNKI database, from inception to July 2016 and retrieval of randomized controlled trials concerning intravenous combined with topical application and single dose intravenous application of tranexamic acid during total hip arthroplasty. Total blood loss, intraoperative blood loss, postoperative blood loss, blood transfusion rate, thrombosis, operation time, and length of hospital stay were analyzed by meta-analysis.

RESULTS AND CONCLUSION: (1) There were seven randomized controlled trials with 620 patients. (2) Meta-analysis results indicated that total blood loss, intraoperative blood loss, postoperative blood loss, and blood transfusion rate were significantly better in the combination group than in the single dose group (P < 0.05). There were no significant differences in thrombosis, operation time, and length of hospital stay between the two methods (P > 0.05). (3) These results suggested that compared with the single dose of intravenous application, intravenous combined with topical application, can significantly reduce the loss of blood volume and blood transfusion rate and did not increase the rate of thrombosis.

中国组织工程研究杂志出版内容重点：人工关节；骨植入物；脊柱；骨折；内固定；数字化骨科；组织工程

Key words: Arthroplasty, Replacement, Hip, Tranexamic Acid, Venous Thrombosis, Hemorrhage, Tissue Engineering

CLC Number:

R318

Wei Zhi-hui, Zhang Zhong-zu, Zhang Ming-hua. Intravenous combined with topical application of tranexamic acid in primary total hip arthroplasty: a meta-analysis of efficacy and safety[J]. Chinese Journal of Tissue Engineering Research, 2017, 21(3): 464-470.

Figures/Tables 4

References

[1] Malchau H,Garellick G,Eisler T,et al.Presidential guest address:the Swedish Hip Registry: increasing the sensitivity by patient outcome data. Clin Orthop Relat Res. 2005;441:19-29.

[2] Stokes ME,Ye X,Shah M,et al.Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 2011;11:135.

[3] Bierbaum BE,Callaghan JJ,Galante JO,et al.An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg. 1999;81:2-10.

[4] Rosencher N,Kerkkamp HE,Macheras G,et al.Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study:blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43:459-469.

[5] Blumberg N,Kirkley SA,Heal JM.A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Am J Surg. 1996;171:324-330.

[6] Friedman RJ. Limit the Bleeding, Limit the Pain in Total Hip and Knee. Arthroplasty. Orthopedics. 2010;33:11-13.

[7] Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406-3417.

[8] Mccormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;(5): 585-617.

[9] Harris RN, Moskal JT, Capps SG,et al. Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study.J Arthroplasty. 2015; 30(2): 192-195.

[10] Min JK, Zhang QH, Li HD, et al. cacy of Bipolar Sealer on Blood Loss in Primary Total Hip Arthroplasty: A Meta-Analysis. Medicine. 2006;(19): 34-35.

[11] Moskal JT, Capps SG..Meta-analysis of Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty. Orthopedics. 2016;3:1-10.

[12] North WT, Mehran N, Davis JJ, et al. Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty:A Double-Blind, Randomized Controlled Trial. J Arthroplasty. 2016;31(5): 1022-1026.

[13] Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty. 2014;29(2): 387-389.

[14] Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials. 1996;17:1-12.

[15] Machin JT, Batta V, Soler JA, et al. Comparison of intra-operative regimes of tranexamic acid administration in primary total hip replacement. Acta Orthop Belg. 2014; 80(2): 228-233.

[16] Wu YG, Zeng Y, Yang TM, et al. The Efficacy and Safety of Combination of Intravenous and Topical Tranexamic Acid in Revision Hip Arthroplasty: A Randomized, Controlled Trial.J Arthroplasty. 2016.

[17] Xie J,Ma J,Yue C,Kang P,et al. Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip Int. 2016;26(1): 36-42.

[18] Yi Z, Shen B, Yang J, et al. Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration.J Bone Joint Surg. 2016;98(12): 983-991.

[19] 张立,王代荣,赵国平,等.氨甲环酸静脉联合局部应用在全髋关节置换术中的疗效评价[J].实用医学杂志,2015,31(20): 3358-3360.

[20] 赵清斌,任姜栋,张晓岗.等. 氨甲环酸静脉或局部及联合应用初次单侧全髋关节置换:围置换期出血及输血率的比较[J].中国组织工程研究,2016,20(4): 459-464.

[21] 朱灿,储小兵,章建华.氨甲环酸3种不同应用方法对全髋关节置换术失血量的影响[J].江西中医药大学学报,2016,28(1): 47-49.

[22] 覃健,余存泰,徐中和,等.全髋关节及全膝关节置换术后隐性失血的临床影响[J].中华骨科杂志,2006,26(5): 323-326.

[23] Murphy GR, Glass GE, Jain A. The Efficacy and Safety of Tranexamic Acid in Cranio-Maxillofacial and Plastic Surgery. J Craniofac Surg. 2016;27(2):374-379.

[24] Cheriyan T, Maier SP, Bianco K,et al.Efficacy of tranexamic acid on surgical bleedingin spine surgery: a meta-analysis. Spine J. 2015;15(4):752-761.

[25] Dunn CJ, Goa KL.Tranexamic acid: a review of its use in surgery and other indications.Drugs. 1999;57(6):1005- 1032.

[26] Liu X, Zhang X,Chen Y, et al.Hidden blood loss after total hip arthroplasty. J Arthroplasty. 2011;26(7): 1100 -1105.

[27] 张成欢,刘云,赵建宁,等.静脉滴注联合局部应用氨甲环酸可减少全髋关节置换后隐性失血[J].中国组织工程研究,2015, 19(44):7071-7076.

[28] Garneti N, Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. Arthroplasty. 2004;19(4):488-492．

[29] Nishihara S, Hamada M. Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis. Bone Joint J. 2015;97(4):458-462.

[30] Gillette BP, DeSimone LJ, Trousdale RT, et al. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res. 2013;471(1):150-154.